Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. Trivett
Patients With Multiple Myeloma Treated With Thalidomide: Evaluation of Clinical Parameters, Cytokines, Angiogenic Markers, Mast Cells and Marrow CD57+ Cytotoxic T Cells as Predictors of Outcome
Haematologica
Hematology
Related publications
Programmed Death 1 Is Highly Expressed on CD8+CD57+ T Cells in Patients With Stable Multiple Sclerosis and Inhibits Their Cytotoxic Response to EBV
Immunology
Allergy
Immunology
Clinical Implications of C-Maf Expression in Plasma Cells From Patients With Multiple Myeloma
Experimental Hematology and Oncology
Cancer Research
Oncology
Hematology
Increased Frequency of CD4+CD57+ Senescent T Cells in Patients With Acute Heart Failure: Exploring New Pathogenic Mechanisms With Clinical Relevance
Journal of Cardiac Failure
Cardiovascular Medicine
Cardiology
Aberrant T Helper 17 Cells and Related Cytokines in Bone Marrow Microenvironment of Patients With Acute Myeloid Leukemia
Clinical and Developmental Immunology
Successful Treatment of Extramedullary Tumors With Low-Dose Thalidomide in Patients With Multiple Myeloma
Internal Medicine
Internal Medicine
Medicine
A Multiepitope of XBP1, CD138 and CS1 Peptides Induces Myeloma-Specific Cytotoxic T Lymphocytes in T Cells of Smoldering Myeloma Patients
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Effect of Thalidomide Therapy on Bone Marrow Angiogenesis in Multiple Myeloma
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Pre-Clinical Evaluation of CD38 Chimeric Antigen Receptor Engineered T Cells for the Treatment of Multiple Myeloma
Haematologica
Hematology
Effect of Thalidomide on Stem Cell Collection and Engraftment in Patients With Multiple Myeloma
Bone Marrow Transplantation
Transplantation
Hematology
